000194155 000__ 03603cam\a2200409\a\4500
000194155 001__ 194155
000194155 005__ 20210513083218.0
000194155 008__ 980106s1997\\\\mdua\\\\\b\\\f101\0\eng\d
000194155 010__ $$a98110039
000194155 035__ $$a(OCoLC)ocm38160933
000194155 035__ $$a194155
000194155 037__ $$a017-024-01612-8$$bGPO
000194155 040__ $$aNLM$$cNLM$$dMUU$$dDLC$$dMMU$$dGPO$$dCNO$$dXTA$$dCLU$$dBTCTA$$dTNT$$dAMAZN$$dORX
000194155 049__ $$aISEA
000194155 05000 $$aRC568.C6$$bM39 1997
000194155 074__ $$a0831-C-12
000194155 074__ $$a0831-C-12 (online)
000194155 0860_ $$aHE 20.3965:175
000194155 24500 $$aMedication development for the treatment of cocaine dependence :$$bissues in clinical efficacy trials /$$ceditors, Betty Tai, Nora Chiang, Peter Bridge.
000194155 260__ $$aRockville, MD :$$bU.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications ;$$a[Washington, D.C. :$$bSupt. of Docs., U.S. G.P.O., distributor],$$c1997.
000194155 300__ $$aiv, 329 p. :$$bill. ;$$c24 cm.
000194155 440_0 $$aNIDA research monograph ;$$v175
000194155 440_0 $$aNIH publication ;$$vno. 98-4125
000194155 500__ $$a"Based on the papers from a technical review ... held on October 20-21, 1994"--p. ii.
000194155 500__ $$aShipping list no.: 98-0092-P.
000194155 504__ $$aIncludes bibliographical references.
000194155 5050_ $$aGoals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research -- Overview of potential treatment medications for cocaine dependence -- Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective -- Management of clinical trials with new medications for cocaine dependence and abuse -- Outcome measurement considerations: pharmacological treatments for substance abuse -- Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials --Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence -- Addiction severity index in clinical efficacy trials of medications for cocaine dependence -- Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment -- Treatment effectiveness score as an outcome measure in clinical trials -- Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis -- Quantitative urine levels of cocaine and other substances of abuse -- Use of quantitative urinalysis in monitoring cocaine use -- Is quantitative urinalysis more sensitive? -- Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine -- Appendix I: Workshop summary outcome measures and success criteria -- Appendix II: Workshop summary clinical decision tree for cocaine addiction pharmacotherapy.
000194155 530__ $$aAlso available via Internet from the NIDA web site (PDF file only).
000194155 650_0 $$aCocaine abuse$$xChemotherapy$$vCongresses.
000194155 650_0 $$aCocaine abuse$$xTreatment$$vCongresses.
000194155 650_0 $$aClinical trials$$vCongresses.
000194155 7001_ $$aTai, Betty.
000194155 7001_ $$aChiang, C. Nora.
000194155 7001_ $$aBridge, Peter.
000194155 7102_ $$aNational Institute on Drug Abuse.$$bOffice of Science Policy and Communications.
000194155 77608 $$iOnline version:$$tMedication development for the treatment of cocaine dependence.$$dRockville, MD : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications ; [Washington, D.C. : Supt. of Docs., U.S. G.P.O., distributor], 1997$$w(OCoLC)623259106
000194155 85200 $$bgen$$hRC568.C6$$iM39$$i1997
000194155 85640 $$zOnline abuse$$uhttp://catalog.hathitrust.org/api/volumes/oclc/38160933.html
000194155 909CO $$ooai:library.usi.edu:194155$$pGLOBAL_SET
000194155 980__ $$aBIB
000194155 980__ $$aBOOK
000194155 983__ $$aOnline